Leronlimab encoding gene therapy - CytoDyn
Latest Information Update: 19 Jul 2022
At a glance
- Originator CytoDyn
- Developer CytoDyn; Oregon Health & Science University
- Class Antiretrovirals; Gene therapies; Monoclonal antibodies
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical HIV infections